Jewell Christopher M - Insider Non-Derivative Transactions at Cartesian Therapeutics, Inc. (RNAC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 2, 2024, Jewell Christopher M's relationship to Cartesian Therapeutics, Inc. (RNAC) is Officer (Chief Scientific Officer), and currently has 778,200 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RNAC insiders.
Data Source: SEC.
Jewell Christopher M - Insider Non-Derivative Transactions at RNAC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 3, 2024 | Acquisition -- (Common Stock) | 778200 | 0 | 778200 |